Suppressor of fused associates with dissemination patterns in patients with glioma

Area of Science:

• Neuro-oncology
• Molecular biology
• Cancer research

Background:

• Gliomas are common brain tumors with poor prognosis, often due to aggressive cell migration.
• Mechanisms driving glioma cell infiltration remain largely unknown.
• The Hedgehog (HH)-Gli signaling pathway is implicated in various cancers.

Purpose of the Study:

• To investigate the role of HH-Gli pathway intermediates in glioma.
• To determine the association between HH-Gli intermediates and clinical parameters in glioma patients.
• To identify novel molecular targets for reducing glioma cell dissemination.

Main Methods:

• Analysis of SuFu expression in three independent glioma patient cohorts (N=1,759).
• In vitro studies involving Glioblastoma Cancer Stem Cells (GB CSC) with modified SuFu expression.
• Correlation analysis between SuFu levels and clinical parameters, including dissemination patterns.

Main Results:

• Elevated Suppressor of Fused (SuFu) levels were significantly associated with higher glioma dissemination.
• Overexpression of SuFu in GB CSC models enhanced cancer stemness properties.
• SuFu overexpression promoted a migratory phenotype in vitro.

Conclusions:

• Suppressor of Fused (SuFu) is identified as a key molecular player in glioma cell migration.
• SuFu's role in promoting stemness and migration suggests it as a potential therapeutic target.
• Developing agents to block SuFu activity could help reduce glioblastoma dissemination.